[The intensive therapy of multiple organ failure in myelotoxic agranulocytosis in a patient with acute leukemia].
Shulutko
E M
EM
Fedanov
A V
AV
Tamarin
I V
IV
Gorelov
V G
VG
Pivnik
A V
AV
Kremenetskaia
A M
AM
Gorodetskiĭ
V M
VM
Kozhurin
S V
SV
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced / Q000150:complications* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects*; D003422:Critical Care / Q000379:methods*; D003561:Cytarabine / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D006801:Humans; D015479:Leukemia, Myelomonocytic, Acute / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009102:Multiple Organ Failure / Q000209:etiology / Q000628:therapy*; D011014:Pneumonia / Q000209:etiology / Q000628:therapy; D012772:Shock, Septic / Q000209:etiology / Q000628:therapy; D013866:Thioguanine / Q000009:adverse effects; D013997:Time Factors
D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin
Intensivnaia terapiia poliorgannoĭ nedostatochnosti pri mielotoksicheskom agranulotsitoze u bol'nogo ostrym leĭkozom.